AmperCap Acquisition Rolls Out $126 Million SPAC to Hunt Its First Target

AmperCap Acquisition Co. is not a tech start‑up with a flagship product, nor a retailer with a growing footprint. It is a special purpose acquisition company – a shell that raises capital from the public markets, parks the cash in a trust, and then has a limited window to consummate a business combination. The filing, an S‑1/A submitted to the SEC on May 22, 2026, reads more like a legal playbook than a corporate prospectus: it spells out the mechanics of the trust account, the redemption rights of shareholders, and the limited role of its underwriters, while offering virtually no insight into any target or operating plan.

The offering in plain terms

The prospectus calls for 12.5 million units to be sold to the public, each unit consisting of one share of common stock and a fraction of a warrant. EarlyBird Capital, Inc. has agreed to purchase the entire offering as the lead underwriter, and UBS is listed as the underwriting syndicate. The units are priced at $10.10 per share, a figure that ensures the trust will hold a minimum of $126.25 million once the offering closes. An initial private‑placement deposit of $5.125 million will be placed in the trust on the closing date, with additional funds added if an “Option Closing” occurs, bringing the balance up to the $10.10‑per‑share target.

Where the money goes – and where it *doesn’t* go

Unlike a traditional IPO, the filing makes it crystal clear that none of the proceeds will be used for operating expenses, debt repayment, working capital, acquisitions, or research and development. The entire $126.25 million sits in a trust account for the benefit of public shareholders. The only scenarios in which the cash can leave the trust are:

1. Redemption upon a business combination – shareholders may elect to have their shares redeemed at the trust price when a merger is completed.
2. Redemption after a charter amendment – if the company changes the redemption rights in its charter, the trust may be tapped to honor those new terms.
3. Full redemption or liquidation – should AmperCap fail to close a deal within its defined “Completion Window,” the trust will be used to either redeem 100 % of the public shares or to liquidate the vehicle and return the cash to investors.
4. Interest earnings – any interest earned on the trust balance may be used for unspecified purposes, but the filing does not detail how that interest will be allocated.

The prospectus also notes that the company will reimburse its representative up to $150,000 for out‑of‑pocket expenses and cover up to $25,000 in counsel fees related to FINRA filings. Those are the only disclosed outlays beyond the trust‑account mechanics.

The bet that investors are buying

In a market where SPACs have fallen out of favor after a 2021 frenzy, AmperCap’s filing is a reminder that the model still attracts capital, albeit with tighter safeguards. The full‑redemption clause is a key selling point: investors can walk away with their money if the sponsor fails to deliver a target, a protection that was less common in earlier SPAC waves.

However, the lack of any disclosed target, industry focus, or strategic rationale introduces a material risk. Potential acquirers will have to convince a skeptical investor base that a viable deal exists within the limited timeframe. The filing does not enumerate any risk factors, but the very nature of a blank‑check vehicle implies several:

• Deal‑flow uncertainty – without a pre‑identified target, the company must source, negotiate, and close a transaction before the deadline, a process that can be derailed by market volatility or competing bids.
• Redemption pressure – if market sentiment turns negative, a wave of shareholder redemptions could deplete the trust and force liquidation, leaving the sponsor with no assets.
• Regulatory scrutiny – SPACs have come under increasing oversight from the SEC, which could impose additional disclosure or procedural requirements that delay or complicate a combination.
• Underwriter exposure – the underwriting agreement explicitly states that UBS and EarlyBird owe no fiduciary duty to the company, underscoring that the underwriters are insulated from the outcome of the business combination.

Context in a cooling SPAC market

Industry coverage notes that the SPAC boom has largely subsided since 2022, with the number of new SPAC IPOs dropping sharply and investors demanding higher transparency. The trust‑only use of proceeds and full‑redemption rights built into AmperCap’s structure reflect that shift. While the filing does not name a sponsor or management team, the involvement of EarlyBird Capital—a firm that has previously sponsored SPACs—suggests that experienced dealmakers are still willing to pursue the model, betting on niche opportunities that may not fit the traditional IPO route.

Analysts observing the market have warned that valuation discipline is now paramount; investors are less willing to accept speculative deals without clear upside. AmperCap’s $126 million war chest is modest by SPAC standards, positioning the vehicle to target mid‑size companies where a strategic merger could unlock value without the scale pressures of mega‑deals.

What to watch next

The filing sets a Completion Window—the period during which the company must secure a business combination. The exact length is not disclosed in the excerpt, but SPACs typically have 24 months from the IPO to close a deal. As the clock ticks, the market will watch for any target announcements, letter of intent filings, or redemption spikes that could signal the health of the vehicle.

If AmperCap identifies a compelling target and executes a merger, the $126 million trust will be released to fund the transaction, potentially providing a runway for growth or a strategic pivot for the acquired company. Conversely, a failure to close a deal would trigger a full redemption of public shares, returning capital to investors but ending the SPAC’s life.

In a landscape where blank‑check companies are under heightened scrutiny, AmperCap’s filing is a textbook example of the new SPAC playbook: raise capital, lock it away, and give shareholders an exit if the sponsor can’t deliver. Whether that playbook writes a success story or a cautionary tale will depend on the elusive target that remains to be named.

---

Key takeaways

• AmperCap Acquisition Co. is a SPAC raising a minimum of $126.25 million in a trust account, with 12.5 million units sold at $10.10 per share.
• All proceeds are locked in the trust; the company cannot use the cash for operating purposes, debt repayment, or acquisitions.
• Investors have a full‑redemption right if no business combination is completed within the defined window, a safeguard that reflects tighter market expectations.
• The filing provides no details on a target, industry focus, or risk factors, leaving the core bet on the sponsor’s ability to find and close a deal.
• In a cooling SPAC market, the structure underscores a shift toward greater investor protection and heightened scrutiny of blank‑check vehicles.